Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 61 AL 75

Neurosteroid PREGS protects neurite growth and survival of newborn neurons in the hippocampal dentate gyrus of APPswe/PS1dE9 mice

Xu B, Yang R, Chang F, Chen L, Xie G, Sokabe M, Chen L.

Curr Alzheimer Res. 2012 Mar;9(3):361-72. doi: 10.2174/156720512800107591.

White matter damage along the uncinate fasciculus contributes to cognitive decline in AD and DLB

Serra L, Cercignani M, Basile B, Spanò B, Perri R, Fadda L, Marra C, Giubilei F, Caltagirone C, Bozzali M.

Curr Alzheimer Res. 2012 Mar;9(3):326-33. doi: 10.2174/156720512800107555.

Roles of glycogen synthase kinase 3 in Alzheimer's disease

Cai Z, Zhao Y, Zhao B.

Curr Alzheimer Res. 2012 Sep;9(7):864-79. doi: 10.2174/156720512802455386.

PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence

Fuso A, Cavallaro RA, Nicolia V, Scarpa S.

Curr Alzheimer Res. 2012 Jun;9(5):527-35. doi: 10.2174/156720512800618053.

Personality characteristics of staff in elderly care-a cross-cultural comparison

Richter J, Aström S, Isaksson U.

Issues Ment Health Nurs. 2012 Feb;33(2):96-100. doi: 10.3109/01612840.2011.624675.

The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy

Yu JT, Tan L.

Mol Neurobiol. 2012 Apr;45(2):314-26. doi: 10.1007/s12035-012-8237-1. Epub 2012 Jan 25.

Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology

Abramowski D, Rabe S, Upadhaya AR, Reichwald J, Danner S, Staab D, Capetillo-Zarate E, Yamaguchi H, Saido TC, Wiederhold KH, Thal DR, Staufenbiel M.

J Neurosci. 2012 Jan 25;32(4):1273-83. doi: 10.1523/JNEUROSCI.4586-11.2012.

Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Curr Drug Targets. 2012 Apr;13(4):483-94. doi: 10.2174/138945012799499794.

The molecular pathology of Alzheimer's disease

Harrington CR.

Neuroimaging Clin N Am. 2012 Feb;22(1):11-22, vii. doi: 10.1016/j.nic.2011.11.003.

MicroRNAs in Alzheimer's disease

Delay C, Mandemakers W, Hébert SS.

Neurobiol Dis. 2012 May;46(2):285-90. doi: 10.1016/j.nbd.2012.01.003. Epub 2012 Jan 17.

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

Benilova I, Karran E, De Strooper B.

Nat Neurosci. 2012 Jan 29;15(3):349-57. doi: 10.1038/nn.3028.

Philadelphia Brief Assessment of Cognition in healthy and clinical Brazilian sample

Pereira DA, Satler C, Medeiros L, Pedroso R, Tomaz C.

Arq Neuropsiquiatr. 2012 Mar;70(3):175-9. Epub 2012 Jan 31.

Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions

Kitazawa M, Medeiros R, Laferla FM.

Curr Pharm Des. 2012;18(8):1131-47. doi: 10.2174/138161212799315786.

The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease

Morley JE, Farr SA, Kumar VB, Armbrecht HJ.

Curr Pharm Des. 2012;18(8):1123-30. doi: 10.2174/138161212799315795.

Solanezumab for the treatment of mild-to-moderate Alzheimer's disease

Imbimbo BP, Ottonello S, Frisardi V, Solfrizzi V, Greco A, Seripa D, Pilotto A, Panza F.

Expert Rev Clin Immunol. 2012 Feb;8(2):135-49. doi: 10.1586/eci.11.93.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias